Board of Directors
The Board of Directors oversees the day-to-day running of our association and the Chairman of the Board is the highest representative of Asebio. The assembly held in December 2017 chose the candidacy with Jordi Martí (Ferrer Internacional) as chairman and Carlos Buesa (Oryzon Genomics), Carmen Eibe (Pharma Mar) and Daniel Ramón (Biopolis) as the three vice presidents. They will hold these offices until late 2019.
Advisor to the pharmaceutical company Ferrer, Jordi Martí has already chaired Asebio's Board of Diretors in the period 2015-2017, as CEO of Celgene. He ls a long long experience in the biotech sector and has been the CEO of the Spanish subsidiary of Amgen between 2003 and 2012.
Daniel Ramon founded Biopolis in 2009 after working for more than 20 years as a professor at the Institute of Agrochemistry and Food Technology (IATA) in Valencia. Since the acquisition of Biopolis by Archer Daniels Midland Company (ADM), he is the R&D Director of the Bioactive Unit .
Co-founder and president since 2001 of the investment company Cross Road Biotech, Castellón was Secretary of State for Health and Consumer Affairs (1996-2000), a position from which he promoted multiple projects of great relevance to the sector.